| abstract |
Provided in the present invention is a compound as an SOS1 inhibitor. Specifically, provided in the present invention is a compound having a structure as represented by the following formula (I), or an optical isomer, a pharmaceutically acceptable salt, a prodrug, a deuterated derivative, a hydrate or a solvate thereof. The compound can be used for treating or preventing diseases or conditions associated with the activity or expression amount of SOS1. |